Hattie Hayes

The approval makes ILM-Blue the first DORC posterior dye product available in China, according to a press release from Zeiss

The lens will be available with the Monarch IV manual delivery system in Q2 and the AutonoMe Automated Pre-Loaded Delivery System in Q3

The partnership will use ocular imaging to build an AI foundation model and identify new genetic targets for degenerative diseases

After a successful inaugural WOS in 2024, the congress will feature new lectures and wetlabs in its sophomore year

SpliceBio continues to actively enroll patients in the ASTRA study and accompanying POLARIS trial

A large-scale study indicates women are more likely to develop the inherited corneal condition

The UN Friends of Vision group meeting coincided with International Women's Day and the UN Commission on the Status of Women

A clinician panel illuminates current treatment paradigms and best practices for reducing treatment burden

The event will include presentations on artificial intelligence, ocular imaging and surgical topics

The encapsulated cell therapy from Neurotech Pharmaceuticals is the first FDA-approved treatment for MacTel

The modifier gene therapies from Ocugen target geographic atrophy and Stargardt disease

This year, the European Society of Cataract and Refractive Surgeons has partnered with the Hellenic Society of Intraocular Implant and Refractive Surgery

The Visumax 800 boasts a faster laser pulse repetition rate for shorter procedures

Researchers indicated that paediatric patients with Leber congenital amaurosis experienced improvements in vision

The biosimilar to aflibercept (Eylea) has already received approval in the EU and US

Francesco Bandello, MD, FEBO, discusses the Diabetic Eye Conditions Coalition and a five-point call to action

According to Apellis and Sobi, pegcetacoplan (Aspaveli) first received marketing authorisation for treatment of paroxysmal nocturnal hemoglobinuria

The UK-based company will debut the tool, called Dr.Noon CVD, at two conferences in March

Professor Anat Loewenstein, MD, speaks about her presentation from the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting

The company shared 5-year results for lenadogene nolparvovec (Lumevoq), administered unilaterally and bilaterally to patients with Leber Hereditary Optic Neuropathy

Mariya Moosajee, MBBS, BSc, PhD, FRCOphth, discusses how Gene Vision is improving patients' lives on a global scale

Researchers from the University of Bristol recorded increased instances of inflammation in particular demographic groups

A qualitative study method illuminates patients’ fears for the future

Intercontinental collaboration is key to unlocking ROP in our lifetime

Pavblu and Skojoy, both from Amgen, are indicated for the treatment of neovascular age-related macular degeneration

The gel addresses necrotic retinal cell death in dry age-related macular degeneration and geographic atrophy without requiring injections

The centre will facilitate research and access to resources for the 450,000 residents of the UK who are affected by sight and hearing loss

Predictive software will use retinal imaging to identify patient risk for Alzheimer and other neurodegenerative diseases

The transferrin vectorised therapy is being investigated for use in patients with dry age-related macular degeneration and geographic atrophy

The commercialisation agreements for the biosimilar to aflibercept (Eylea) cover Israel, major parts of Europe and the Asia-Pacific Region